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Abstract
Scavenger receptors belong to a superfamily of proteins that are structurally heterogeneous and encompass the
miscellaneous group of transmembrane proteins and soluble secretory extracellular domain. They are functionally
diverse as they are involved in various disorders and biological pathways and their major function in innate immunity
and homeostasis. Numerous scavenger receptors have been discovered so far and are apportioned in various classes
(A-L). Scavenger receptors are documented as pattern recognition receptors and known to act in coordination with
other co-receptors such as Toll-like receptors in generating the immune responses against a repertoire of ligands
such as microbial pathogens, non-self, intracellular and modified self-molecules through various diverse mechanisms
like adhesion, endocytosis and phagocytosis etc. Unlike, most of the scavenger receptors discussed below have both
membrane and soluble forms that participate in scavenging; the role of a potential scavenging receptor Angiotensin-Converting Enzyme-2 has also been discussed whereby only its soluble form might participate in preventing
the pathogen entry and replication, unlike its membrane-bound form. This review majorly gives an insight on the
functional aspect of scavenger receptors in host defence and describes their mode of action extensively in various
immune pathways involved with each receptor type.
Keywords: Scavenger receptors, Immunity, PAMPs, Signalling pathways, ACE-2
Background
Scavenger receptors (SRs) were shown for the first
time on macrophages to function in endocytosis and
degradation of modified (acetylated) low-density lipoproteins (LDLs) [1]. SRs are a structurally heterogeneous superfamily of proteins that belong to different
classes with very little or no structural resemblance.
The only characteristic that designates various classes
is their competence to bind mutual ligands. SRs show
interactions with modified self-molecules, damageassociated molecular patterns (DAMPs), non-self molecules like preserved pathogen-associated molecular
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patterns (PAMPs) on microbial pathogens (lipopolysaccharide (LPS) and lipoteichoic acid (LTA)). They
also recognize unmodified endogenous proteins, lipoproteins, apoptotic cells and polyionic ligands such as
carbohydrates, proteoglycans, cholesterol ester and
phospholipids etc. Host cells are effective guardians
of the immune response through the expression of
complex surveillance systems, including the Pattern
Recognition Receptors (PRRs) [2]. Scavenger receptors are membrane-associated pattern recognition
receptors (PRRs) [3–5] that act as phagocytic receptors mediating direct non-opsonic uptake of pathogenic microbes and/or their products. SRs may partner
with other PRRs like TLRs (Toll-like receptors) or
multimolecular complexes on various cell types and
participate in diverse functions like signalling other
than scavenging. Recognition of pathogens by SRs
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Fig. 1 Schematic representation of various members of Types A Scavenger receptor: SR-A1, SR-A3, SR-A4, SR-A5, SR-A6. Various domains are shown
in the key within the picture

on antigen-presenting cells leads to inflammatory
response followed by phagocytosis, processing of antigens and subsequent presentation on MHC class I and
II molecules thus, linking innate and adaptive immune
responses [6]. SRs show expression on various cell
types that are potential portals of pathogen entry like
macrophages, dendritic cells, neutrophils, microglia, B
cells, endothelial and epithelial cells [7, 8]. SRs play a
significant role in host defence by recognizing countless microbial antigens at the portals of pathogen invasion and activating downstream immune responses to
fight and eliminate the pathogens [9].
Due to their functional diversity and involvement
in various diseased conditions and immunity-related
signalling pathways this review extensively focus upon
the emergence of mammalian scavenger receptor as
PRRs, their involvement in host defence and mode of
action in various immune pathways involved with each
receptor type.
Types of Scavenger receptors

Scavenger receptors are classified based on their nucleotide sequence alignment and protein structure [10,
11]. Each class is divided into subclasses that include
members, which share structural features [12]. Based
on the current understanding of scavenger receptors
and proposed nomenclature, this review discusses 12
classes and their subclasses of mammalian scavenger

receptors and one potential scavenger receptor, Angiotensin-converting enzyme-2 (ACE-2).
Class A

Class A scavenger receptors have an N-terminus cytoplasmic domain, single transmembrane section and
a big extracellular C-terminus part involved in ligand
identification. Class A SRs contains a collagen domain,
and a type-A cysteine-rich domain (SRCR) or a C-type
lectin domain (CLEC). Members include SR-A1 (SCARA1 OR MSR1), SR-A3 (SCAR-A3 or CSR1), SR-A4
(SRCL), SR-A5 (SCAR-A5) and SR-A6 (MACRO)
(Fig. 1). The linked SRCR domain of SR-A1 facilitates
communications with other membrane-bound receptors while the collagen domain is responsible for ligand
recognition. SR-A1 binds to lipopolysaccharide (LPS),
lipoteichoic acid (LTA) and bacterial CpG DNA. In the
presence of LPS, SR-A1 interacts with Toll-like receptor 4 (TLR4) and stimulates NF-κB and inflammatory
cytokine production in macrophages in presence of
LPS [13]. Also, it binds to the purified lipid A moiety
of LPS from E. coli where it is involved in the clearance and detoxification of endotoxins [14]. Similarly,
SR-A1 also participates in host defence by binding and
clearance of LTA and/or gram-positive bacteria from
tissues and the circulation such as (Streptococcus pyogenes, Streptococcus agalactiae, Staphylococcus aureus,
Enterococcus hirae and Listeria monocytogenes) [15].
SR-A1 can facilitate the internalization of Neisseria
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meningitides, Listeria monocytogenes and Staphylococcus aureus [16–18]. The SRCR domain of SR-A6 mediates the attachment of bacteria and LPS. The positive
arginine area that exists outwardly on the exterior of
SR-A6 is deficient in the case of SR-A1 [19]. SR-A1
and SR-A6 are also involved in the aberrant dispersal
of splenic macrophages if depleted. In mice, deficiency
of SR-A1 and SR-A6 results in distorted spleen morphology and low circulating antibody levels (IgM and
IgG3) for bacterial polysaccharides. Ligand specificities
and structural features suggest that SR-A1 and SR-A6
show functional dissimilarity contrary to a study, which
recognizes overlapping, but separate endogenous and
microbial ligands, comprising some N. meningitides
external proteins binding to both of these receptors
[20]. SR-A1 can generate an adaptive immune response
by stimulating antigen binding, internalization and
antigen presentation in alliance with HSP70 members
[21]. SR-A1 also cooperates with TLR4 to phagocytize
Escherichia coli, while SR-A1 and TLR2 collaborate in
the phagocytosis of Staphylococcus aureus [22]. SR-A6
partners with TLR2 and CD14 in the identification of
the Mycobacterium tuberculosis glycolipid to produce
a pro-inflammatory reaction [23]. Macrophage associated cell surface SR-A6 is inhibited by Herpes simplex virus type 1 (HSV-1) jointly with proteoglycans
to facilitate adsorption of the virus to keratinocytes
epithelial cells [24]. SR-A1 participates in the internalization via clathrin-dependent endocytosis (CDE)
or clathrin-independent endocytosis (CIE) methods
and the latter stimulates apoptosis. In antigen-presenting cells (APCs), SR-A1 facilitates internalization and
phagocytosis by a lipid raft-dependent method. It was
reported that cumulative surface expression of SR-A1
along with its co-receptor MERTK M2 resulted in the
engulfment of apoptotic bodies by macrophages [25].
As for SCAR-A3 or CSR1 (cellular stress response protein), its expression could be improved by oxidative
stress and functions as a cellular stress response gene
to scavenge reactive oxygen species (ROS). A recent
study reported SCAR-A3 as the potential prognostic
indicator in Hand Foot and Mouth Disease (HFMD)
and a boosted expression of SCAR-A3 was observed
in severe HFMD patients compared with the control
group [26]. SCAR-A4 or SRCL (scavenger receptor with
C-type lectin) belongs to collectin family PRRs and the
C-terminal domain contains a C-type lectin, instead of
an SRCR domain. It generates an immune response on
binding to heat-killed S. aureus, E. coli and S. cerevisiae
yeast particles [27] and facilitates non-opsonic phagocytosis of zymosan [28]. SCAR-A5 is a newly recognized class A scavenger receptor that binds to modified
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LDL particles instead of heat-inactivated E. coli and S.
aureus, signifying its part as a PRR in innate immunity
[29]. Increased SCAR-A5 expression causes inactivation of signal transducer and activator of transcription
3 (STAT3), a chief transcriptional watchdog in proinflammatory gene expression [30].
Class B

Class B scavenger receptors comprise a conserved CD36
domain (Fig. 2). It comprises three members: SR-B1
(SCAR-B1), LIMP2 (SCAR-B2), and CD36 (SCAR-B3).
This class binds to a wide array of ligands like viruses and
bacteria, HDL particles and correlates with the amplified danger of infertility, atherosclerosis and reduced
natural immunity. CD36 (SCAR-B3) has two transmembrane domains and both its N and C terminus are cytoplasmic. The C-terminal tail might be the spot of signal
transduction and links with SRC family kinases, including FYN, YES and LYN [31]. The C-terminus of CD36
holds a CXCX5K motif, which is located on the cytosolic ends of the T cell co-receptors CD4 and CD8 that
play a role as a docking place for SRC kinases. CD36 is
known to stimulate mitogen-activated protein kinases
(MAPKs) and binds with a noticeable array of transmembrane proteins that comprise TLR2, TLR4 TLR6,
β1 integrin, β2 integrin, β5 integrin and CD9, CD81. In
response to lipoteichoic acid or diacylated lipoproteins,
CD36 generates an immune response in association
with the TLR2-TLR6 heterodimer complex [32, 33]. The
SR-B1 (SCAR-B1) has two splice variants entitled SR-BI
and SR-BII and has an indistinguishable loop structure
as of CD36. A variety of pathogenic ligands comprising
Alexa Fluor 488-labeled live E. coli K12, K1, S. aureus,
S. typhimurium and Listeria monocytogenes bind and
internalize CLA-1 and CAL-2 stably transfected HeLa
and HEK293 cells. These cells also bind to and internalize dead bacteria and are involved in its clearance hence
their role in infection and sepsis [34]. Another study
demonstrated internalization of E. coli, LPS, and chaperonin 60 (GroEL) in HeLa cells due to overexpression
of CLA-1, CLA-2, and CD36 receptors indicating that
SR-B1 receptors plays part in pathogen detection and
facilitate bacteria-associated inflammation and signalling [35]. Hepatic SR-B1 acts as a critical defensive factor in sepsis thus endorsing hepatic SR-B1 facilitated LPS
clearance that delivers a therapeutic approach for sepsis
[36]. SR-BI plays role in hepatitis C virus (HCV) internalization and cross-presentation by human dendritic cells
(DCs) and may influence the design of HCV vaccines and
immunotherapeutic methods [37]. The role of SR-B1 and
LOX1 on bronchial epithelial cells (BECs) showed that
SRs participate in the in vitro activation of human airway cells triggered by TLR3 ligand, dsRNA and SRs act as
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Fig. 2 Schematic representation of SR-B receptor class shows interaction with TLR2/6 and TLR4 receptors. TLR2/6 binds to LTA of gram-positive
bacteria and TLR4 on interaction with LPS of gram-negative bacteria shows activation of proinflammatory signaling cascade, SRC family kinases and
MAPKs

transporters, enabling dsRNA entrance and transport to
the dsRNA-sensing receptors on BECs [38]. In malaria,
SR-B1 acts against host defence for Plasmodium infection by stimulating sporozoite penetration in liver cells
and consequent intracellular parasite growth [39]. SR-B1
binds to the diverse spectrum of receptors; it binds and
recognizes Mycobacterium tuberculosis in vitro but is
known to play only an insignificant role in anti-mycobacterial immunity in vivo [40]. Overexpressed SR-B1 in
epithelial cells of pyometra-affected uteri is potentially
involved in endometrial bacterial adhesion and involvement in the pathogenesis of pyometra in general [41]. In
our study on milk derived goat mammary epithelial cells
(GMECs) we have validated the presence and expression of SR-B1 and its role in E. coli infection. Through
esiRNA based silencing technique, SCARB1 expression
significantly affects the TLR4-MyD88 and TRIF pathway
genes following infection with E.coli. Also, this receptor
is involved in mediating endocytosis of live bacteria in
GMECs. Intriguingly, CD36 has a role to play in the clearance of numerous bacterial and protozoan pathogens.
A variety of bacteria like E. coli, Klebsiella pneumoniae,

S. typhimurium, S. aureus, and Enterococcus faecalis are
phagocytized in CD36 overexpressing HeLa cells via
JNK-Mediated Signaling and in association with TLR2/4
[42]. Also, the binding to beta-glucan of Cryptococcus
neoformans provided evidence of its role in antifungal defence in an experimental mice model in vivo [43].
CD36 deficit presents resistance to mycobacterial infectivity, which is due to decreased intracellular existence of
Mycobacterium in the Cd36 -/- macrophages [44]. In goat
mammary epithelial cells, CD36 is involved in LPS based
pro-inflammatory response and TLR4 mediated E. coli
endocytosis in GMECs [45].
LIMP-2 (lysosome membrane protein 2) or SCARB2 is known to be a receptor for enterovirus 71 (EV71)
and shows binding with both of its soluble and cell surface forms. LIMP2 is recognized for enterovirus 71 so
that its expression is propagated in normal unsusceptible
cell lines, development of cytopathic effects. It is also a
receptor for development of infection for coxsackievirus
A16 (CVA16) (a weak pathogen). Enterovirus 71 belongs
to human enterovirus species A and along with CVA16,
is recurrently linked with human foot and mouth disease
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[46]. L929 cells expressing human LIMP-2 infected with
coxsackievirus A7, coxsackievirus A14 and coxsackievirus 16 require the receptor for entrance into host cells
and the expansion of human foot and mouth disease
[47]. Subsequently, during EV71 infection, LIMP-2 along
with acidic conditions also function as a receptor for viral
binding, virus internalization, viral uncoating and therefore infection efficiency [48].
Class C

Class C scavenger receptors have only been described in
Drosophila melanogaster and lacks mammalian counterparts. Drosophila SR-CI (dSR-CI) on Schneider 2
cells (derived from a primary culture of late stage Drosophila embryos) is expressed as an undefined bacterial
PRR for both gram-positive and gram-negative bacteria.
Cross-competition experiments and dsRNAi-mediated
gene silencing methods have suggested dSR-CI to be a
common candidate PRR for E. coli and S. aureus binding
and optimal bacterial phagocytosis by S2 Cells. Additionally, dSR-CII is detected on early embryos and is predicted to be a transmembrane protein with no role in
innate immunity at later stages. Also, dSR-CIII and dSRCIV classes are predicted to be present in secreted soluble form [49].
Class D

CD68 (named Macrosialin in the mouse) is the only
member belonging to class D of scavenger receptors. Class D scavenger receptors contain a mucin-like
domain, a proline-rich center, lysosome-associated
membrane glycoprotein (LAMP) domains, single transmembrane and a small cytoplasmic tail [50]. CD68 receptor is abundant on immune cells like free monocytes,
tissue-specific macrophages in the peritoneum, liver,
lungs, spleen, Langerhans cells, and microglia where it
scavenges oxLDL binds to lectins, selectins and mediate
endocytosis and phagocytosis. CD68 being a macrophage
marker is involved in differentiation of hematopoietic
cells of the monocyte/macrophage descent. The function of CD68 in antigen presenting and processing is
ambiguous. But, the involvement of lysosomal associated membrane proteins (LAMP) in CD68 related activities are highly assumed due to their structural homology.
In CD68 knockout mice, phagosome lysosome fusion
and overall phagolysosome formation are regulated by
LAMP-1/2. Lower levels of CD68 are also expressed in
CD4+ T lymphocytes, CD19+ B lymphocytes, basophils
and intestinal neutrophils from patients with inflammatory bowel syndrome. While as in normal mucosal tissue
CD68 + neutrophils are absent [51]. In vivo CD68 participates in discriminating M1 and M2 macrophage divergence in association with transcription factor markers
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such as pSTAT1, CMAF and RBP-J [52] and association
of TLR4 in (microglial cell) macrophages in brain tissue
in response to stimuli like LPS and IFN-γ upregulates
the CD68 expression significantly [53]. CD68 plays a role
in host resistance by preventing the uptake of malarial
sporozoite in liver tissue macrophages hence acting as a
potential receptor for malarial pathogen [54]. Contrary to
this in small intestinal epithelial cells, CD68 was reported
to be putatively involved in antigen processing and presentation together with other factors in the processing of
intestinal pathogens [55]. In summary, the participation
of CD68 in immunity and inflammation is still ambiguous and needs further validation.
Class E

Class E scavenger receptors belong to the NK cell C-type
lectin-like (CLEC) receptor family. It has four members: SR-E1 (LOX-1) (Fig. 3a), SR-E2 (Dectin-1), SR-E3
(MRC1) and SR-E4 (ASGPR1). The SR-E1 is also called
lectin-like oxidized low-density lipoprotein receptor
(LOX-1). Human SR-E1 has an N-cytoplasmic region,
a transmembrane region, an extracellular coiled-coil
‘neck’ region and a C-type lectin-like domain. SR-E1
binds diverse ligands like apoptotic cells, gram-positive,
gram-negative bacteria and acute phase C-reactive proteins. SR-E1 participates in antigen presentation on
MHC class-I of dendritic cells in association with HSP70
[56]. SR-E1 also mediates signal transduction that triggers an important feature of pro-inflammatory response
in immune and vascular cells i.e., NF-κB activation [57].
It acts as an intermediate between NF- κB and its targets. In Chinese hamster ovary-K1 (CHO-K1) cells, stably expressing LOX-1 can bind FITC-labeled S. aureus
and E. coli in both static and non-static conditions,
and bovine aortic endothelial cells (BAEC) also bind
to labelled S. aureus that is supported by the fact that
binding was repressed with poly (I) and an anti-LOX-1
mAb [58]. Knockout of LOX-1 decreased pro-inflammatory response, reduced inflammation during sepsis, lung oedema, stopped neutrophil overreaction, and
amplified neutrophil employment to infection sites in a
murine model of polymicrobial sepsis. Thus, indicating
that SR-E1 is a significant intermediary of intracellular
signalling during infection and promotes immune suppression if absent [59]. In the brain abscess model, TLR2dependent signals affect the degree of SR-E1 induction,
suggesting possible cross-talk amongst TLRs and SRs.
Both SR-A1 and SR-E1 together generate an antibacterial immune response in the CNS parenchyma [56]. Also,
TLR2 activation is triggered when SR-E1 together with
SR-F1 binds to outer membrane protein A (OmpA) of
Enterobacteriaceae (Klebsiella pneumonia) and thus controls many phases of the innate immune response [60].
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Fig. 3 (a) LOX-1 on interaction with TLR2 on infection with PTX3 of Klebsiella Pneumonia shows OmpA internalization and stimulation of
proinflammatory response. On binding to diverse microbial ligands it participates in antigen presentation on MHC class-I of dendritic cells in
association with heat-shock protein HSP70. (b) Dectin-1 on binding to diverse antigens dimerize and activate CARD9, Bcl10, and MALT10, while on
binding to TLR2/6 activates TRAF6, IRAK1, and IRAK4 leading to activation of proinflammatory cytokines and chemokines

SR-E2 or Dectin-1 being an innate immunity PRR is
expressed principally on macrophages, DCs, and neutrophils. This receptor mediates both the internalization and
cellular responses of various bacteria, fungi and parasites through unique processes [61]. Dectin-1 stimulates
diversity of cellular reactions like phagocytosis; cytokine
production and the respiratory burst via Syk/CARD9
dependent and Syk- independent signalling pathways
[62]. Dentin-1 recognizes unidentified endogenous
ligands on CD4 + and CD8 + T cells hence acting as a
co-stimulatory molecule through an unknown response.
Due to its prevalence on DCs and macrophages of medullary areas of the thymus, it functions in thymocyte
growth and its expression on CD11c ( +) splenic DCs in
areas of the spleen and lymph nodes suggests it to act as
a co-receptor for triggering T cells [63]. Dectin-1 plays a
major role against the systemic Candida glabrata challenge. Splenocytes were collected from infected dectin1-deficient and wild-type mice and the levels of TNF- α,
IL-6, IFN-ϒ and IL-17 in supernatant indicated lower Th
cell responses. Also, dectin-1-and dectin-2 deficient mice
showed considerably increased fungal loads while dectin-1 renders the host sensitive to C. glabrata infection,
unlike dectin-2 [64] (Fig. 3b).

SR-E3 or MRC1, the human mannose receptor
(CD206) is another transmembrane glycoprotein belonging to this class. Most tissue macrophages, DCs and
selected lymphatic or liver endothelial cells express it
predominantly. It is involved in phagocytosis of mannosylated glycoproteins, or receptor-mediated antigen presentation. As a homeostatic PRR on macrophages, it binds
to high mannose N-linked glycoproteins on the surface
of pathogens, pituitary hormones in the circulation and
scavenges via phagocytosis and lysosomal degradation.
SR-E3 after participation in recognizing and processing antigenic bacteria help in the removal of myeloperoxidases that are released by the pathogenic bacteria to
prevent complement activation and damage to host tissue. CD206 binds to a variety of pathogens like M. tuberculosis, S. pneumonia, Yersinia pestis, Candida albicans,
Pneumocystis carinii, Cryptococcus neoformans, HIV,
influenza virus, dengue virus, and Leishmania species.
MR-mediated uptake by macrophages in tissues during infection is a striking method for effective and targeted delivery of drug transporters such as liposomes,
microparticles, nanoparticles and dendrimers for infectious diseases like tuberculosis and also for cancer imaging, diagnosis and therapy [65]. SR-E3 is expressed on
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dendritic epidermal cells in a condition called atopic dermatitis where it acts as a differentiation marker of immature monocyte-derived DCs [66] and in COPD (severe
chronic obstructive pulmonary disease) overexpression
of SR-E3 along with other CD markers on alveolar macrophages function in COPD pathogenesis [67]. In hepatitis B virus mouse model F4/80+SR-E3+CD80lo/+ hepatic
macrophages endorse the immunosuppressive action of
regulatory T cells thus offering novel understandings into
the immunomodulation in HBV infection [68].
SR-E4 or asialoglycoprotein receptor 1 (ASGPR1) also
designated the Ashwell receptor is found on the surface
of hepatocytes that recognize, internalize and transport
glycoproteins deficient in terminal sialic acid residues
and those which have galactose or N-acetylgalactosamine
residues via the route of receptor-mediated endocytosis. SR-E4 binds to a range of clinically essential plasma
proteins like transferrin, IgA, apoptotic cells, fibronectin,
alkaline phosphatase and many immune cells. During
liver diseases impaired SR-E4 receptor is related to the
increased pro-inflammatory release of TNF-α and IL-6
in kupffer cells [69]. Additionally, when mice deficient in
functional hepatic SR-E4 (receptor-deficient, RD), and
wild-type (WT) controls were intravenously administered with mitogens, the former displayed increased proinflammatory cytokine expression, caspase activation and
buildup of CD8 + T cells versus normal WT mice. Thus,
deficiency of this receptor may lead to liver diseases as
it has protective effects against T cell-mediated hepatitis [70]. Similarly, in SR-E4 knockout hepatitis E virusinfected PLC/PRF/5 cells various assays revealed direct
attachment of ASGR1 and ASGR2 to ORF2 protein of
virus and participation in regulating the viral attachment
and internalization steps and not in viral emancipation.
Also, HeLa cell lines stably expressing SR-E4 scavenger
receptors demonstrated amplified virus-binding competence [71].
Class F

Class F scavenger receptors have three members: SREC1
(SCAR-F1), SREC2 (SCAR-F2) and SCAR-F3 (also called
MEGF10) and have epidermal growth factor (EGF) and
EGF-like domains. One of the distinct structural properties of these receptors is that they lack visible signalling
motifs on short cytosolic ends. They also have a higher
inclination to oligomerize and bind large, multivalent
ligands. SCAR-F1 is a membrane-bound receptor with
EGF-like domains on the outside and unusually extended
proline- and serine-rich cytoplasmic extensions. SCARF1 binds to a variety of pathogens, both exogenous and
endogenous. It binds to fungal pathogens in a β-glucan
dependent approach and facilitates host defence alongside Candida albicans and Cryptococcus neoformans.
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SCAR-F1 along with SCAR-B3 mediated cytokine production and innate immunity in response to fungal infections [72]. Also, SCAR-F1 through an endocytic receptor
in co-operation with TLR2 binds to non-structural protein 3 (NS3) of hepatitis C virus and participate in virus
uptake and cross-presentation [43]. SCAR-F1 in association with TLR4 leads to LPS induced pro-infalmmatory
response through NF-kB and P kinase pathways on RAW
and HEK 293 cells and function in the endocytosis of
peptides and antigen presentation [73]. SCAR-F1 is present on DCs and helps in the removal of apoptotic cells
in association with C1q/phosphatidylserine complexes.
Deficiency of SCAR-F1 has been shown to impair efferocytosis in vitro and in vivo and trigger systemic lupus
erythematosus, an autoimmune disorder in SCAR-F1
deficient mice [74] (Fig. 4).
SCAR-F2 is originally recognized on endothelial cells
and is expressed by macrophages as well but its scavenging function is yet to be reported. It favourably forms
heterodimers with SCAR-F1 in trans and these heterodimers lack SR activities losing the competence to mediate
ligand recognition [75].
MEGF10 (Multiple EGF-like domains 10) or SCARF3 is the third newest member in this group that was
recently reported to express on brain macrophages
(myosatellite and astrocytes). It plays a role as a receptor
for binding to a complement protein called C1Q and is
hence involved in apoptotic cell clearance in the mouse
cerebellum and deficiency of MEGF10 in mice showed
paucity in the apoptotic cells clearance in the mammalian brain [76]. MEGF10 is reported as an astrocytic
phagocytic receptor for neuronal debris and unnecessary
synapses in ischemic injured and developing brain [77].
MEGF10 is an ortholog of Drosophila Draper [78] and C.
elegans CED-1 [79] that help to mediate axon pruning by
glial cells in flies and phagocytosis of apoptotic cells in
worms. It is a critical protein in the synapse remodeling
underlying neural circuit refinement and has important
implications for understanding learning and memory as
well as neurological disease processes. Developing mice
deficient in MEGF10 receptor fail to normally refine their
retinogeniculate connections and retain excess functional
synapses [80].
Class G

Chemokine 16 (CXCL16) is a single receptor in this class
that has a CXC-chemokine domain with conserved arginine residues (Fig. 5). It is also called SR-PSOX (scavenger receptor for phosphatidylserine and oxidized LDL)
due to their amino acid sequence similarity. It was primarily recognized in human monocytic cell line THP-1
as a receptor for scavenging and delivery of oxLDL and
as a chemoattractant for stimulated T cells and bone
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Fig. 4 SCAR-F1 on binding to diverse ligands like B-glucans, OmpA, NS3 in presence of TLR2 activates proinflammatory response, Antigen
cross-presentation and viral uptake. On interaction with TLR4 in presence of LPS it activates MAP kinases following activation of various
transcriptional factors like p38 and JNK that mediate extracellular release of IL6, TNF-α and INF-β

Fig. 5 SCAR-G on immune cell activates various immune related pathways like Th1 immune response via activation of IL12 and IFN-γ. On binding
to gram-negative and gram-positive bacteria this receptor activates phagocytosis of bacteria into mature APCs following activation of IL12, TNF-α
and p40 that helps to convert Th0 into Th1 cells
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marrow plasma cells via receptor interaction with CXCchemokine receptor 6 (CXCR6). It is likewise expressed
on various immune cells like DCs, macrophages, [81]
smooth muscle cells and endothelial cells. Novel CXCL16
on the surface of APCs function as an adhesion molecule that can be converted into a soluble form through
proteolytic degradation of transmembrane CXCL16
mediated through (A Disintegrin and metalloproteinase
domain-containing protein 10) ADAM10, which acts as
a CXCL16 sheddase. The soluble chemokine, SR-PSOX/
CXCL16 is interferon-regulated that triggers the CXCR6
receptor expressed by T cells, natural killer T cells [82]
and a range of CXCR6 ( +) leukocytes. In chronic inflammation, a characteristic of inflammatory bowel disease
is that the serum concentrations of soluble SR-PSOX/
CXCL16 are elevated in patients and that this soluble
cytokine triggers phagocytosis of bacterial pathogens as
well as Th 1 immune response through the production
of IL 12, TNF- α and INF γ [83]. The deficiency of SRPSOX/CXCL16 however, results in a reduced number of
natural killer T cells in the liver and diminished release of
cytokines like IFN- γ and IL-4 thus explaining its critical
role in Th1 immune response [84]. Also, SR‐PSOX/CXC
ligand CXCL16 not only attracts but also facilitates the
strong adhesion of CXCL16 expressing macrophages and
DCs with CXCR6 expressing activated T cells and natural
killer T cells [85]. In the liver, a specific NK cell population (liver-resident NK) is critical for local innate immunity that expresses a unique repertoire of chemokine
receptors including CXCR6 that regulates selective
movement in reaction to the chemotactic stimuli [86].
Class H

Class H scavenger receptors are transmembrane protein receptors with fasciclin, EGF-like, and lamin-type
EGF-like domains comprising scavenger receptor 1,
FEEL-1 (also called stabilin-1 and CLEVER1) and FEEL-2
(also called stabilin-2 and HARE). Both are structurally
homologous and display analogous domain organization
in extracellular regions.
FEEL-1/Stablin-1 is principally expressed on macrophages, mononuclear cells, hematopoietic stem cells,
and endothelial cells. Its expression is inducible in reaction to diverse proinflammatory stimuli. Stablin-1 as a
leucocyte adhesion molecule is involved in regulating
lymphocyte recirculation and trans movement to inflammation sites in vitro [87]. Another study by Karikoshi
et al. confirmed that stablin-1 participates in the movement of T cells and B cells across HEVs in vivo and blockade of this receptor inhibited the relocation of blood
monocytes and lymphocytes into the spot of infection
[88]. Stabilin-1 binds a broad spectrum of ligands, such
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as modified LDLs, apoptotic cells and microparticles
from gram-positive and negative bacteria. Stablin-1 provides a defence mechanism to cells against bacteria and
the direct interaction of stablin-1 and S. aureus is confirmed by using a blocking antibody against the transiently expressing receptor on CHO-1 cells [89].
FEEL-2/Stablin-2 has a conventional NPxY-like endocytic motif in the cytoplasmic region and like stablin-1 it
is expressed on HS endothelial cells facilitating lymphocyte trafficking to the liver sinusoidal endothelium [90]
and binding a variety of ligands such as acLDLs, heparin, apoptotic, necrotic cells and microparticles of grampositive and negative bacteria. Stablin-2 also participates
in regulating lymphocyte recirculation and migration to
the liver sinusoidal endothelium via interaction with fasciclin 1 (FAS1) domains of stabilin-2 with lymphocyte
expressed αMβ2 integrin. Future findings are necessitated to examine and authenticate the possible function
of stabilin-2 in leukocyte trafficking to other tissues like
the spleen and lymph nodes [91].
Class I

Class I receptors are the CD163 family of molecules that
are categorized by the presence of numerous group B
SRCR in their extracellular region. SCAR-I1 (also known
as CD163A) is a transmembrane type 1-membrane glycoprotein with nine SRCR domains that are predominantly
expressed in monocytes and macrophages acting as an
endocytic receptor for haptoglobin-haemoglobin complexes to endorse the clearance of plasma haemoglobin.
It was also called the ‘haemoglobin scavenger receptor’
due to its part as a haemoglobin receptor. It contributes
to functions like apoptotic cell sequestration, clearance
and inactivation of pro-inflammatory cytokine and TNF‐
related weak inducer of apoptosis (TWEAK) [92]. Like
scavenger receptor SR-PSOX, SCAR-I1 is highly predisposed to cleavage by exofacial proteases and exists in soluble forms in plasma thus acting as a potential biomarker
for infection and autoimmune diseases [93]. However,
the proteolytic products function contrarily than the precursor receptor as the soluble form can counteract the
growth of pathogens by acting as an iron chelator [94].
CD163A in host–pathogen interactions deliver host protection through its function as a macrophage receptor
for gram-negative and positive bacteria. Its expression
on human monocytes also provides defence through
bacteria-induced proinflammatory cytokine production
confirmed through using antagonistic antibodies against
CD163A. It also has an immunomodulatory function as
it activates intracellular protein tyrosine kinase-dependent signalling secretion of IL-6 and IL-10 [95]. CD163-L1
(also known as CD163B) is another member of this class
with 12 SRCR domains. The cytoplasmic splice variants
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Fig. 6 SR-J/RAGE interacts with TLR4 receptor in response to synergistic interaction between HMGB1-LPS complex in activating the macrophages
through phosphorylation of MAPK p38 and activation of NF-κB following release to proinflammatory molecules like IL16, IL1-β and TNF-α

recognized so far are the full-tail length variant (CD163L1α) and the short-tail variant (CD163-L1β). The subcellular location of these two variants in HEK293 cells
differs as the former is an exterior receptor and the latter
is in the intracellular section [96]. It is highly expressed
in co-localization with CD163 in various types of macrophages like in alveolar macrophages, glia, and kupffer
cells. Its involvement in the differentiation of monocytes
into macrophages is dependent on various exogenous
stimuli; M-CSF, IL6 and IL10 but is repressed by the
cytokines such as IL-4, IL-13, TNF-α, LPS/IFN-γ [97].
Being an endocytic receptor, it is internalized through a
clathrin-mediated pathway unlike other members of this
group, CD163 and CD5 and also does show the same
ligand preferences as of CD163 ligands such as the haptoglobin–haemoglobin complex or numerous bacteria.
The third CD163 family member is CD163c-a
(SCART1) or CD5 with five SRCR domains. Two isoforms
differ in the number of SRCR domains, one with two
domains and another with four SRCR domains. SCART1
and SCART2 are the isoforms of this class expressed on

mice γδ T cells, lymph node, trachea, and lungs [98] and
CD163 and SCART1 genes are expressed in bovine γδ T
cells, monocytes, lymph node, lungs, and intestinal lymphocytes [99]. These SRCR families of receptors exist in
both bound and soluble forms, whereby the membranebound form is involved in ligand binding. CD5 binds
to numerous fungal cells such as Schizosaccharomyces
pombe, Candida albicans, and Cryptococcus neoformans through its ectodomain and purified zymosan but
not gram-negative or positive bacteria or purified LPS,
LTA or peptidoglycans components. CD5 binds to fungal particles through conserved fungal components on
the surface called β-glucans and trigger phosphorylation
of MEK and ERK1/2 and thus triggers MAPK signalling
cascade. This interaction further results in the significant
release of cytokine IL-8 from HEK293 cells expressing
CD5. Whether CD5 binds to microbial ligands in association with TLRs and participate in adaptive immune
responses needs further investigation [100]. The fourth
human CD163 family molecule is CD163c-b (SCART2)
or CD6 that has high structural and functional homology
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Fig. 7 Membrane bound ACE-2 receptor binds to the spike proteins on SARS-CoV-2, which helps in its internalization. However, soluble form of this
receptor (sACE-2) acts a scavenger to prevent the internalization of virus by inhibiting the binding process

with CD5 ectodomain. Both CD5 and CD6 are lymphocytic receptors found on T and B cells. CD6 is differentially expressed on CD56 NK cell subpopulation and
trigger cytokines (INF-γ and TNF-α) and chemokines
such as IP-10 and CXCL1 [101]. In Sjögren’s syndrome,
CD166 is highly expressed on epithelial cells. Unlike
CD5, both soluble and membrane-bound forms of CD6
bind to gram-negative and positive bacteria while its soluble form shows less affinity to fungal species (binds to
saprophytic but not pathogenic). CD6 binds to both LPS
and LTA components in presence of calcium and activate
the MAPK signalling cascade [102].
Class J

RAGE (receptor for advanced glycation end-products)
is the only member of class J of scavenger receptors
belonging to the Ig superfamily of cell surface molecules
(Fig. 6). The ectodomain of this receptor is known to
show various ligand interactions with amyloid-β-protein,
HMGB1, and microbial PAMPs and DAMPs [103]. As a
PRR it is involved in chronic inflammation and immunity, share common ligands and pathways with TLRs thus

cooperating synergistically. RAGE interacts with TLR4/2
associated adaptor proteins (TIRAP and MyD88) to activate downstream signalling pathways [104]. HMGB1, a
ligand of RAGE works in cooperation with LPS in triggering the macrophages through phosphorylation of
MAPK p38 and activation of NF-kB as seen in experimentally induced arthritis in mice [105]. While HMGB1LPS complexes use TLR4, the HMGB1-Pam3CSK4
complexes use TLR2. RAGE-HMGB1 interactions are
stabilized by heparin sulfate that readily forms a complex
with RAGE at the cell surface before binding to HMGB1
[106]. S100 protein family members also interact with
RAGE triggering immune responses in cooperation with
TLR4 and activation of p38 MAPK, NF-κB and downstream signalling molecules [107]. Despite evidence that
S100A8/A9 complex also interacts with TLR4 directly via
MD2, [108] it is yet to be investigated if glycans expressed
on TLR4 also mediate binding between the S100A8/A9
and TLR4. Also, in vitro analysis indicates that RAGE has
a higher affinity with S100A8/A9 than TLR4, whereby the
former interaction is linked with inflammation-mediated
carcinogenesis and the latter with autoimmune disorders
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and infection [109]. Direct interaction of RAGE with
LPS molecule was also determined through competition assay with another RAGE ligand, AGE-BSA [110]
and produced comparable immune reactions as that seen
with TLR4 binding in the in vitro and in vivo. Unlike,
HMGB1–RAGE interactions in synergy with LPS and
TLR4 has been demonstrated, the RAGE-TLR4 interactions in response to LPS or whole bacteria are still ambiguous. Like membrane-bound forms, the soluble form of
RAGE called sRAGE also functions in various processes
and disease pathogenesis [111].
Class K

The only receptor of class K is CD44 and is a hyaluronan
(HA) receptor that shows ligand binding with proteoglycans, growth factors, cytokines, and matrix metalloproteinase through its extracellular domains. ADAM10,
ADAM17, and MMP14 act as sheddase of membrane
bound CD44 in various tumour cells lines. The external
ectodomain cleavage product of this receptor is biologically active [112] and it participates in intracellular signalling through the Src family of kinases such as Src,
Lck, Fyn and Lyn and activates small Rho GTPases.
CD44 has a wide ligand spectrum and interactions with
a diverse range of receptors thereby activating multiple
signalling pathways. The most important interactions
in the context of immunity are with TLRs. In acute pulmonary infection, CD44 prevents overstated inflammatory responses to LPS. Intratracheal LPS treatment
in CD44-/- mice show a marked increase in NF-κB,
inflammatory cell recruitment, raised chemokine expression in lung tissue in vivo and reduced induction of the
negative regulators of TLR4 signalling pathways [113]. A
direct association between CD44 and TLR2 was shown
in a study that demonstrates, on stimulation with TLR2
ligand, zymosan, CD44 promoted NF-κB deactivation,
suppression of proinflammatory cytokine and that CD44
and TLR2 function together in diminishing TLR-mediated inflammation in CD44 + / + macrophages derived
from mice as compared to CD44-/-macrophages [114].
CD44 also functions in response with hyaluronan and
LPS in association with TLR4 against the septic response
to LPS and show-decreased serum IL-6 and TNFα in
CD + / + mice [115]. However, in osteoarthritis, activation of TLR2 and TLR4 induce IL-1β and TNF-α release
that notably increased CD44 gene expression and protein
concentrations in human macrophages, whereas blocking
CD44 with anti-CD44 Ab or HA show opposite results
[116]. CD44 also aids in host defence against Group A
Streptococcus (GAS) through the interaction of CD44 to
capsular HA polysaccharide of the bacteria. In transgenic
mice expressing a CD44-antisense transgene, no bacteria
were internalized by macrophages, thus adding to the fact
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that CD44 functions as a phagocytic receptor via HA signalling. In macrophages, the molecular mass of HA also
determines if the bacteria undergo phagocytosis or not.
While degradation of HA with protease, hyaluronidase
augmented internalization of GAS by macrophages [117].
CD44-HA interactions are also responsible for progression towards gastric cancer after Helicobacter pylori
infection whereby a cascade is triggered, which leads
to degeneration of parietal cells followed by neoplasia
[118]. Similarly in pneumonia, CD44 plays a positive but
opposite role in the advancement of infection instigated
by Escherichia coli and Streptococcus species. Unlike
E.coli based pneumonia, S. pneumonia and Klebsiella
pneumonia induced pneumonia shows decreased CD44–
HA-mediated signalling and downstream activation of
inflammatory pathways [119]. Overall these reports indicate CD44 prolong bacterial infections by decreasing
lung inflammations and increasing bacterial diffusion to
other locations. In viral diseases such as HIV and hepatitis C, CD44 plays the opposite role in infection. In HIV,
the virus acquires the CD44 molecules from the host and
decreases the activation of blood mononuclear cells, CD4
( +) T cells (by not triggering protein kinase C-α release),
and M7-Lue cells in presence of endogenous HA which
shows a defensive role in HIV by interfering with CD44HA interactions [120]. While as in hepatitis C, the CD44
expression is amplified in infected cells with HCV when
induced with HA that increases IP-10 (gamma interferon-inducible protein 10) expression via CD44–TLR2–
MyD88 interactions [121].
Class L

Class L has two receptors named: SR-L1 (also called
LDLR-related protein 1 (LRP1)) or CD91 and SR-L2
(LRP2 or Megalin). They belong to the LDLR gene family and SR-L1 is the one most studied so far. SR-L1 functions uniquely as a scavenger receptor thus scavenging
the extracellular ligands or bioactive compounds (crosspresentation) that come in its contact as well as an extracellular sensor that senses the same ligands and transfer
the signal to the cell’s interior for activation of classical
signal transduction pathways (costimulation). While
doing so it is known to bind over 100 diverse ligands
whose functions and interactions with other co-receptors
and signal transducers mainly remain unknown. One of
the important ligands is defensins that are endogenous
peptides with antimicrobial action alongside a broad
spectrum of pathogens including bacteria, fungi, viruses,
and many parasites. SR-L1 expressed on dendritic cells
is upregulated by human defensins, HNP-1 alpha defensin or HBD-1 and thus show the existence of an autocrine loop [122]. SR-L1 act as a receptor for heat shock
proteins such as gp96, hsp90, hsp70, and calreticulin on

Taban et al. Cell Communication and Signaling

(2022) 20:2

APCs (Macrophages, T cells and DCs) and is one of the
potential receptors that mediate APC- HSP interactions.
It conducts signal to APCs for their activation in presence of immunogenic HSPs followed by stimulation of
NF-κB and p38 MAPK and release of TNF-α, IL-1β, IL-6,
IL-12, and GM-CSF [123] and costimulatory and maturation markers like CD80, CD86, CD40, and MHC II
[124]. The release of proinflammatory cytokines triggers
chronic inflammation during increased levels of hsp70 in
synovial fluid from swollen joints of rheumatoid arthritis patients that triggers autoimmunity [125]. However,
whether CD91 functions along with TLRs on immune
cells in inflammatory processes needs more validation.
Megalin or SR-L2 is another endocytic receptor that
belongs to this class, which is expressed on various cells.
Megalin is expressed at the blood–brain barrier and lack
of this receptor leads to neuroinflammatory processes
and impaired neurogenesis by triggering the discharge
of pro-inflammatory cytokines such as IL-1β, IL-6 and
TNF-α on activation of microglial and astroglial cells
and attenuating the suppressor of cytokine signalling-3
(SOCS3) in cortical and hippocampal regions [126].
Angiotensin‑converting Enzyme 2 (ACE‑2): a scavenger
receptor?

Many receptors that participate in the entry of viruses
in cells, rather than evoking an immune response
against the viral particles that happens in the case of
SRs, facilitate the replication and dissemination of
the pathogen. One of such receptors is Angiotensinconverting Enzyme 2 ACE-2. It is a transmembrane
metallopeptidase that functions as a monocarboxypeptidase to cleave diverse regulatory peptides such at
the carboxyl-terminal of Angiotensins II and I, bradykinin, kinetensin, and neurotensin [127, 128]. It functions as a vasodilator, unlike ACE-1. ACE-2 was first
isolated from Vero E6 (African green monkey kidney
cell line) that interact with the S1 domain of the SARSCoV (Coronavirus) S protein through S1-Ig interaction. ACE-2 permits the cell–cell fusion and then
replication of the virus that was confirmed when the
soluble form of ACE-2 inhibited the S1-Ig interactions
with Vero E6 cells and ACE2-transfected 293 T cells
shows signs of cytopathicity on infection respectively.
ACE-2 is a principal receptor for SARS-CoV was also
confirmed in vivo on established mouse animal models [129, 130]. A novel virus, SARS-CoV-2 originated
from bats and pangolins as possible intermediate hosts
showed structural homology, 76.5% identity in amino
acid sequences of spike proteins with SARS-CoV [131].
Also, the spike proteins of SARS-CoV-2 recognize and
bind to human ACE-2 with high affinity than SARSCoV thus contributing to a higher rate of transmission
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[132]. Overexpression of membrane-bound ACE-2
on HeLa cells from diverse species like humans, civets, pigs, other than mouse show SARS-Cov-2 uses
only ACE-2 receptor for entry and not other receptors like aminopeptidase N and dipeptidyl peptidase 4
[133]. Of note, however, most of the scavenger receptors discussed above have both membrane-bound
forms and soluble forms that participate in scavenging.
But ACE-2 only in its soluble form might participate
in preventing the viral entry and replication unlike
its membrane form, which is one of the properties of
scavenger receptors (Fig. 7). It is suggested that free
ACE-2 competitively binds to the spike proteins of
CoV-2 thus preventing the virus to bind ACE-2 found
excessively on alveolar epithelial type II and hence the
viral spread. Also, it prevents lung injury by negatively
regulating the Renin-Angiotensin pathway (RAS) by
increasing the ratio of ACE/ACE-2 [134]. Thus, classifying ACE-2 as a prospective scavenger receptor
will be assessed if additional information becomes
available.

Conclusions
Initially, the role of scavenger receptors was confined
to their involvement in lipoprotein binding. With time
it was clear just like other PPRs, SRs have dynamically
complex interactions with an extraordinary repertoire of
ligands like PAMPs, DAPMs, modified self-molecules etc.
This versatility is because this family of receptors is classified in various classes each with diverse functional roles
in host–pathogen interactions, innate immunity, adaptive
immune response, inflammation signaling, ligand delivery and antigen presentation etc. Also, different SRs can
bind to the same type of ligands and a single SR can show
interaction with a variety of pathogenic ligands. Another
important property that enables these receptors to have
a dynamic behaviour is to have a reversible interaction
with various co-receptors in response to ligands thus
taking part in homeostasis and in combatting infections.
Interestingly, each receptor type can induce inflammation to control infection under some conditions while
having an anti-inflammatory response in some other
conditions. But mostly SRs are capable to contribute to
pathogen elimination by controlling the recruitment and
the activation of phagocytic cells and regulating inflammatory response through proinflammatory cytokine
production. Differential responses generated by a single receptor against different ligands and with various
co-receptors need to be comprehensively studied. In
our study, we conclude SCARB1 (Class B receptor) to
play a vital role in the E.coli-induced activation of TLR4
signaling cascades thus providing a deeper insight into
host pathogen interactions. Therapeutic tools involving
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functional manipulation of these receptors through various approaches are attractive prospects to explore their
role as therapeutic targets in inflammatory diseases and
present an opportunity for the development of clinical
therapies to target autoimmunity. Also, sophisticated
techniques like proteomics, transcriptomic approaches,
biophysical methods and super-resolution techniques
are required to understand the signalling complexes and
clusters in inflammation signalling pathways and the
biology of scavenger receptors overall.
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